Cardiol Therapeutics (CRDL) Institutional Ownership $1.20 -0.10 (-7.69%) Closing price 04:00 PM EasternExtended Trading$1.25 +0.05 (+3.75%) As of 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cardiol Therapeutics (NASDAQ:CRDL)CurrentInstitutional OwnershipPercentage12.49%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$4.06MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.07M Get CRDL Insider Trade Alerts Want to know when executives and insiders are buying or selling Cardiol Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CRDL Institutional Buying and Selling by Quarter Cardiol Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/21/2025PVG Asset Management Corp487,295$624K3.0%N/A0.590% 2/17/2025 Cetera Investment Advisers43,547$56K0.0%N/A0.053% 2/14/2025 AdvisorShares Investments LLC882,488$1.13M0.2%-24.6%1.068% 2/13/2025 Envestnet Asset Management Inc.309,684$398K0.0%N/A0.375% 2/11/2025 Virtu Financial LLC48,031$61K0.0%N/A0.058% 2/10/2025 Tejara Capital Ltd3,115,437$3.99M2.6%+75.9%3.771% 2/6/2025 Atria Investments Inc135,891$174K0.0%N/A0.164% 2/6/2025 Jones Financial Companies Lllp19,847$25K0.0%N/A0.024% 1/27/2025 Lion Street Advisors LLC307,666$396K0.1%+12.6%0.372% 11/15/2024 Jane Street Group LLC14,759$29K0.0%N/A0.018% Get the Latest News and Ratings for CRDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/13/2024 Townsquare Capital LLC13,745$27K0.0%N/A0.017% 10/24/2024 Wealth Enhancement Advisory Services LLC13,700$27K0.0%N/A0.020% 10/21/2024 Foundations Investment Advisors LLC161,950$321K0.0%+237.4%0.235% 10/10/2024 Lion Street Advisors LLC273,281$544K0.2%+7.9%0.396% 8/8/2024 AdvisorShares Investments LLC1,466,972$2.93M0.5%+12.7%2.126% 8/2/2024 Foundations Investment Advisors LLC48,000$97K0.0%N/A0.069% 7/17/2024 Baader Bank Aktiengesellschaft29,028$59K0.0%N/A0.042% 7/12/2024 Lion Street Advisors LLC253,281$505K0.2%+31.4%0.367% 5/10/2024 MMCAP International Inc. SPC2,566,125$4.65M0.6%-13.1%3.758% 2/14/2024 AdvisorShares Investments LLC1,189,978$1M0.2%-1.3%1.821% 2/9/2024 AXS Investments LLC697,651$579K0.1%-9.8%1.068% 11/15/2023 Tejara Capital Ltd645,457$578K0.3%+29.9%0.996% 11/15/2023 Laird Norton Trust Company LLC100,000$90K0.0%+63.1%0.154% 11/13/2023 Tejara Capital Ltd645,457$578K0.4%+29.9%0.996% 11/6/2023 AdvisorShares Investments LLC1,205,788$1.11M0.3%-1.1%1.861% 10/10/2023 FNY Investment Advisers LLC33,305$30K0.0%N/A0.051% 8/11/2023 Tejara Capital Ltd497,061$442K0.2%+12.8%0.775% 8/10/2023 AXS Investments LLC1,299,076$1.16M0.3%-24.8%2.026% 8/9/2023 AdvisorShares Investments LLC1,219,738$1.09M0.3%+3.4%1.902% 8/2/2023 Bank of Montreal Can112,179$110K0.0%N/A0.175% 7/13/2023 Cambridge Investment Research Advisors Inc.76,611$68K0.0%+66.5%0.120% 5/12/2023 AXS Investments LLC1,727,827$844K0.3%N/A2.698% 5/11/2023 MMCAP International Inc. SPC3,153,400$1.54M0.3%-6.0%4.924% 5/9/2023 AdvisorShares Investments LLC1,179,738$575K0.2%+7.2%1.842% 2/9/2023 Mirae Asset Global Investments Co. Ltd.1,094,040$557K0.0%+25.7%1.708% 2/1/2023 Bank of Montreal Can90,000$61K0.0%+511.0%0.141% 8/15/2022 MMCAP International Inc. SPC3,353,400$4.43M0.4%+3.1%5.414% 8/11/2022 Marble Harbor Investment Counsel LLC38,150$50K0.0%+32.0%0.062% 8/2/2022 Thompson Davis & CO. Inc.28,400$37K0.0%N/A0.046% 7/26/2022 Mirae Asset Global Investments Co. Ltd.1,356,620$1.78M0.0%-2.3%2.190% 9/9 on TSLA from June to January (Ad)Please take a look at THIS case study on Target (TGT) You’ll see exactly how the tool works to trade long and short, even when the markets seem to be predicting the exact opposite. Now, this tool has been so accurate over recent months that I’m planning to send you 14 more real-world examples of winning trades that anyone using this tool could have captured. And it’s all building to Monday, February 24 @ 1pm ET when I’ll bring the tool to the public for the first time and show you how you can put it on your own charts!Tap here to catch the TGT case study and learn more6/2/2022 Mirae Asset Global Investments Co. Ltd.1,388,836$2.15M0.0%+32.9%2.243% 5/11/2022 MMCAP International Inc. SPC3,253,400$4.98M0.3%+3.2%7.294% 2/9/2022 MMCAP International Inc. SPC3,153,200$5.83M0.4%N/A7.069% 1/25/2022Private Ocean LLC20,651$38K0.0%+275.5%0.046% 1/11/2022 Brookstone Capital Management15,887$27K0.0%N/A0.036% 11/12/2021 Renaissance Technologies LLC144,900$598K0.0%N/A0.334% 11/12/2021Vident Investment Advisory LLC50,566$208K0.0%N/A0.117% 11/10/2021 Marble Harbor Investment Counsel LLC22,000$91K0.0%N/A0.051% 11/5/2021 Advisor Group Holdings Inc.15,800$65K0.0%N/A0.036% (Data available from 1/1/2016 forward) CRDL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CRDL shares? During the previous two years, 20 institutional investors and hedge funds held shares of Cardiol Therapeutics. The most heavily invested institutionals were MMCAP International Inc. SPC ($4.65M), Tejara Capital Ltd ($3.99M), AdvisorShares Investments LLC ($1.13M), PVG Asset Management Corp ($624K), AXS Investments LLC ($579K), Envestnet Asset Management Inc. ($398K), and Lion Street Advisors LLC ($396K).Learn more on CRDL's institutional investors. What percentage of Cardiol Therapeutics stock is owned by institutional investors? 12.49% of Cardiol Therapeutics stock is owned by institutional investors. Learn more on CRDL's institutional investor holdings. Which institutional investors have been buying Cardiol Therapeutics stock? Of the 19 institutional investors that purchased Cardiol Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AXS Investments LLC ($1.73M), Tejara Capital Ltd ($1.70M), PVG Asset Management Corp ($487.30K), Envestnet Asset Management Inc. ($309.68K), AdvisorShares Investments LLC ($283.94K), Foundations Investment Advisors LLC ($161.95K), and Atria Investments Inc ($135.89K). How much institutional buying is happening at Cardiol Therapeutics? Institutional investors have bought a total of 5,316,363 shares in the last 24 months. This purchase volume represents approximately $5.48M in transactions. Which Cardiol Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Cardiol Therapeutics stock in the last 24 months: MMCAP International Inc. SPC ($587.18K), AXS Investments LLC ($504.64K), and AdvisorShares Investments LLC ($318.14K). How much institutional selling is happening at Cardiol Therapeutics? Institutional investors have sold a total of 1,409,951 shares in the last 24 months. This volume of shares sold represents approximately $1.64M in transactions. Related Companies ATXS Major Shareholders AURA Major Shareholders PHAT Major Shareholders CMRX Major Shareholders ORKA Major Shareholders ATAI Major Shareholders RVNC Major Shareholders PRME Major Shareholders ESPR Major Shareholders RGNX Major Shareholders This page (NASDAQ:CRDL) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRDL Stock Alerts